Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 526 publications.

Hudgens S, Regnault A, McLeod LD, Martin M, Eremenco S. Clinical outcomes assessment in a multi-cultural context: measurement challenges and recommendations. Presented at the International Society for Quality of Life Research Conference; December 17, 2015.

Lee S, Wolf D, Feagan B, Lichtenstein G, Andrews E, Stidham R, Aberra M, Aguilar H, Kayhan C, Kosutic G, Sen D, Golembesky A, Hasan I, Spearman M, Loftus E. An observational study of certolizumab pegol in Crohn's disease - an adverse events of interest analysis with 5869 patient-years at risk. Poster presented at the Crohn's and Colitis Foundation of America's Clinical and Research Conference; December 10, 2015. Orlando, FL.

Hess LM, Rajan N, Winfree K, Davey P, Ball M, Knox H, Graham C. Cost analyses in the US and Japan: a cross-country comparative analysis applied to the PRONOUNCE trial in non-squamous non-small cell lung cancer. Adv Ther. 2015 Dec 9;32(12):1248-62. doi: 10.1007/s12325-015-0270-9

Montserrat-Capdevila J, Godoy P, Marsal JR, Barbe F, Galvan L. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam Pract. 2015 Dec 8;16:173. doi: 10.1186/s12875-015-0387-6

Liede A, Fairchild A, Friedman S, Amelio J, Hallett DC, Mansfield CA, Metcalfe KA. Risk-reducing surgery and cancer-related distress among female BRCA1 and BRCA2 mutation carriers. Poster presented at the 2015 San Antonio Breast Cancer Symposium; December 8, 2015. San Antonio, TX.

Darden CM, Price MA, Kaye JA, Sherif BN, Marion S, Tzivelekis S, Garcia J, Chandler D. Same-day administration of pegfilgrastim following myelosuppressive chemotherapy: practices and rationale. Blood. 2015 Dec 3;126(23):5585. doi: 10.1182/blood.V126.23.5585.5585

Hall AJ, Naleway AL, Esterberg EJ, Moua K, Donald J, DeBess EE, Biggs C, Schmidt M. Incidence of medically-attended acute gastroenteritis and norovirus infection across the age spectrum. Poster presented at the ID Week 2015 Conference; October 2015. San Diego, CA. [abstract] Open Forum Infect Dis. 2015 Dec; 2(1 Suppl). doi: 10.1093/ofid/ofv131.181

Fernandez MM, Wang J, Ye X, Kwong WJ, Sherif B, Hogue S, Sherrill B. Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2 score slanted greater than or equal to 2. SAGE Open Med. 2015 Dec. doi: 10.1177/2050312115613350

Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Marin C, Ma CS, Zint K, Elsaesser A, Baretls DB, Lip GY. Antithrombotic treatment patterns in 10,871 patients with newly diagnosed non-valvular atrial fibrillation: the GLORIA-AF Registry Program, Phase II. Am J Med. 2015 Dec;128(12):1303-1313. doi: 10.1016/j.amjmed.2015.07.013

Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M. High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb. 2015 Dec 1;22(12):1287-304. doi: 10.5551/jat.28852

Winnette R, Zárate V, Machnicki G, Demuro-Mercon C, Gawlicki M, Gnanasakthy A. Patient-reported outcomes in Latin America: implementation in research and role in emerging HTA systems. Value in Health Regional Issues. 2015 Dec;8:49-55. doi: 10.1016/j.vhri.2015.03.008

Ajmera MR, Raval AD, Zhou S, Wei W, Bhattacharya R, Pan C, Sambamoorthi U. A real-world observational study of time to treatment intensification among elderly patients with inadequately controlled type 2 diabetes mellitus. J Manag Care Spec Pharm. 2015 Dec;21(12):1184-93.

Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ. Risk of out-of-hospital sudden cardiac death in users of domperidone, proton pump inhibitors, or metoclopramide: a population-based nested case-control study. Drug Saf. 2015 Dec;38(12):1187-99. doi: 10.1007/s40264-015-0338-0.

Li L, Kulldorff M, Russek-Cohen E, Kawai AT, Hua W. Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1304-12. doi: 10.1002/pds.3885

Schwab PE, MacLean E, Chioda M, Moll K, Pasquale M, Mardekian J, Futch T. NSCLC observations combining medical charts and administrative claims data. Poster presented at the 2015 AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5, 2015. Boston, MA. [abstract] Mol Tar Can Ther. 2015 Dec 1; 14(12 S2).

Belozeroff V, Chertow GM, Graham CN, Dehmel D, Parfrey PS, Briggs AH. Economic evaluation of cinacalcet in the United States: the EVOLVE trial. Value Health. 2015 Dec;18(8):1079-87. doi: 10.1016/j.jval.2015.08.007

Novick D, Montgomery WS, Aguado J, Peng X, Brugnoli R, Haro JM. Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder? Asia Pac Psychiatry. 2015 Dec;7(4):427-35. doi: 10.1111/appy.12189

Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-effectiveness of chemotherapy for breast cancer and age effect in older women. Value Health. 2015 Dec;18(8):1070-8. doi: 10.1016/j.jval.2015.08.008

Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007–2010 after the 2006 introduction of bevacizumab. Lung Cancer. 2015 Dec;90(3):442-50.

Hahn KA, Hatch EE, Rothman KJ, Mikkelsen EM, Brogly SB, Sorensen HT, Riis AH, Wise LA. History of oral contraceptive use and risk of spontaneous abortion. Ann Epidemiol. 2015 Dec;25(12):936-941 e. doi: 10.1016/j.annepidem.2015.09.001

Lupo PJ, Danysh HE, Symanski E, Langlois PH, Cai Y, Swartz MD. Neighborhood-based socioeconomic position and risk of oral clefts among offspring. Am J Public Health. 2015 Dec;105(12):2518-25. doi: 10.2105/AJPH.2015.302804

Aranda E, Aparicio J, Alonso V, Garcia-Albeniz X, Garcia-Alfonso P, Salazar R, Valladares M, Vera R, Vieitez JM, Garcia-Carbonero R. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015. Clin Transl Oncol. 2015 Dec;17(12):972-81. doi: 10.1007/s12094-015-1434-4

Turner AJ, Fichera E, Sutton M. The effects of in-utero exposure to influenza on the child mental health and longevity of a British cohort. Presented at the 2015 CLOSER Conference; November 30, 2015. London, United Kingdom.

Basarir H, Brennan A, Jacques R, Pollard DJ, Stevens K, Freeman J. The cost-effectiveness of the Kids in Control OF Food (KICk-OFF) structured education programme for adolescents with type 1 diabetes. Presented at the 2015 British Society for Paediatric Endocrinology and Diabetes; November 27, 2015. Sheffield, United Kingdom.

Rodes-Cabau J, Horlick E, Ibrahim R, Cheema AN, Labinaz M, Nadeem N, Osten M, Cote M, Marsal JR, Rivest D, Marrero A, Houde C. Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: the CANOA randomized clinical trial. JAMA. 2015 Nov 24;314(20):2147-54. doi: 10.1001/jama.2015.13919

McMichael AJ, Rolison JJ, Boeri M, O'Kane J, O'Neill T, Kee F. Challenges for the stratified medicine paradigm in treating chronic mental illness. Time to pay attention to what counts. Poster presented at the 6th Annual UKCRC Public Health Research Centre of Excellence Conference; November 19, 2015. Edinburgh, United Kingdom.

Kohler RE, Goyal RK, Lich KH, Domino ME, Wheeler SB. Association between medical home enrollment and health care utilization and costs among breast cancer patients in a state Medicaid program. Cancer. 2015 Nov 15;121(22):3975-81. doi: 10.1002/cncr.29596

Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT. Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy. Cancer. 2015 Nov 15;121(22):4071-9. doi: 10.1002/cncr.29611

Lebwohl M, Gottlieb A, Elewski B, Rich P, Jazayeri S, Reich K, Nyirady J, Zhao Y, Tran MH, McLeod L, Mordin M, Nelson L, Strober B. Secukinumab impact on patient-reported psoriasis experiences: analysis of the psoriasis symptom diary from the ERASURE and FIXTURE trials. Poster presented at the SDPA 13th Annual Fall Dermatology Conference; November 12, 2015. Orlando, FL. Previously presented at the 73rd Annual Meeting of the American Academy of Dermatology.

Marsh K, Moller J, Basarir H, Detzel P. The economic impact of SHAPE formula for the children of overweight and obese mothers. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 11, 2015. Milan, Italy.

Nash Smyth E, La E, Talbird S, Li L, Kaye JA, Lin AB, Bowman L. Treatment patterns and health care resource use (HCRU) associated with repeatedly treated metastatic squamous cell carcinoma of the head and neck (SCCHN) in the United Kingdom (UK). Poster presented at the 2015 ISPOR 18th Annual European Congress; November 9, 2015. Milan, Italy.

Doward L. PROs, payers and the 5th hurdle. Presented at the 2015 ISPOR 18th Annual European Congress; November 7, 2015. Milan, Italy.

Singh M, Rebordosa C, Bernholz J, Sharma N. Epidemiology and genetics of cystic fibrosis in Asia: in preparation for the next-generation treatments. Respirology. 2015 Nov 6;20(8):1172-81. doi: 10.1111/resp.12656

McLeod L, Mallya AG, Fox T, Zhao Y, Mordin M, Strober B. Psoriasis patients with PASI90 response achieve greater health-related quality of life improvements than those with PASI75 response. Poster presented at the 16th Annual Las Vegas Dermatology Seminar; November 5, 2015. Las Vegas, NV. Previously presented at the 23rd European Academy of Dermatology and Venereology Congress.

Lebwohl M, Gottlieb A, Elewski B, Rich P, Jazayeri S, Reich K, Nyirady J, Zhao Y, Tran MH, McLeod L, Mordin M, Nelson L, Strober B. Secukinumab impact on patient-reported psoriasis experiences: analysis of the psoriasis symptom diary from the ERASURE and FIXTURE trials. Poster presented at the 16th Annual Las Vegas Dermatology Seminar; November 5, 2015. Las Vegas, NV. Previously presented at the 73rd Annual Meeting of the American Academy of Dermatology.

Yaylali E, Farnham PG, Hicks KA, Honeycutt A, Sansom SL, Tucker EL. Developing a dynamic compartmental model of HIV in the United States. Poster presented at the Informs Annual Meeting; November 3, 2015. Philadelphia, PA.

Barnett C, Denton BT, Montie JE. Developing optimal biomarker-based prostate cancer screening policies. Presented at the 2015 INFORMS Annual Meeting; November 2, 2015. Philadelphia, PA.

Mauskopf JA, Mullins D, Earnshaw SR. Budget impact analysis I: a 6-step approach. Presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Rodriguez A, Garcia-Esteban R, Basterretxea M, Lertxundi A, Rodriguez‐Bernal C, Iniguez C, Rodriguez‐Dehli C, Tardon A, Espada M, Sunyer J, Morales E. Associations of maternal circulating 25-hydroxyvitamin D3 concentration with pregnancy and birth outcomes. BJOG. 2015 Nov;122(12):1695-704. doi: 10.1111/1471-0528.13074

Schembari A, de Hoogh K, Pedersen M, Dadvand P, Martinez D, Hoek G, Petherick ES, Wright J, Nieuwenhuijsen MJ. Ambient air pollution and newborn size and adiposity at birth: differences by maternal ethnicity (the Born in Bradford Study Cohort). Environ Health Perspect. 2015 Nov;123(11):1208-15. doi: 10.1289/ehp.1408675

Hatch EE, Hahn KA, Mikkelsen EM, Riis EH, Sorensen HT, Rothman KJ, Wise LA. Pre-gravid oral contraceptive use in relation to birth weight: a prospective cohort study. Eur J Epidemiol. 2015 Nov;30(11):1199-208.

Danysh H, Zhang K, Mitchell LE, Scheurer ME, Lupo PL. Maternal residential proximity to roadways during pregnancy and childhood central nervous system tumors: a population-based assessment in Texas, 2003-2009. Presented at the 47th Congress of the International Society of Paediatric Oncology; October 10, 2015. Cape Town, South Africa. [abstract] Pediatr Blood Cancer. 2015 Nov; 62(S4). Previously presented at the Brain Tumor Epidemiology Consortium 2015 Annual Conference.

Stanford RH, Nagar S, Lin X, O'Connor RD. Use of ICS/LABA on asthma exacerbation risk in patients within a medical group. J Manag Care Pharm. 2015 Nov;21(11):1014-9.

Williams V, McLeod L, Nelson L. Advances in the evaluation of longitudinal construct validity of clinical outcome assessments. Ther Innov Regul Sci. 2015 Nov;49(6):805-12. doi: 10.1177/2168479015609103

Candrilli S, Kurosky SK. Recent trends in anaphylaxis-related hospitalization in the United States. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy. [abstract] Value Health. 2015 Nov; 18(7):A503.

Whalley D, Hauber AB, Crawford SR, Posner J, Doward L, Levitan B, Hemels M, Valgardsson VS. Patients' priorities for treatment in moderate to severe COPD. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Whalley D, Hauber AB, Crawford SR, Posner J, Doward L, Levitan B, Hemels M, Valgardsson VS. Patients' priorities for treatment in severe asthma. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Park EM, Check DK, Yopp JM, Deal AM, Edwards TP, Rosenstein DL. An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancer. Psychooncology. 2015 Nov;24(11):1471-6. doi: 10.1002/pon.3757

Poulos C, Kinter E, Posner J, van Beek J. A comparison of stated preferences for injectable disease-modifying treatments for multiple sclerosis: compliant vs. non-compliant patients. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.

Kurosky S, Mitra D, Zanotti G, Kaye JA. Patient characteristics and treatment patterns in ER+/HER2- metastatic breast cancer in the United Kingdom: results from a retrospective medical record review. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.